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IN human hepatoma HepG2 cell line curdlan
sulphate enhances basal and interleukin-6-stimu-
lated ￿ brinogen and antichymotrypsin (ACT)
synthesis, slightly increases basal ceruloplasmin
production and exerts only minor effects on
alpha-1-proteinase inhibitor and transferrin. Curd-
lan sulphate may, at least in part, affect protein
synthesis at a pretranslational level, as the ex-
pression of ACTmRNA was found to be increased,
whereas intracellular enzyme, manganese super-
oxide dismutase mRNA level was decreased in the
cell culture treated with curdlan sulphate. Gel
mobility shift analysis revealed that curdlan sul-
phate increases the DNA binding activity of NF- B
and C/EBP, suggesting that these transcription
factors may participate in the regulatory effects of
curdlan sulphate in HepG2 cells.
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Introduction
Host defence potentiators, substances which
improve host homeostasis, act mainly by re-
storation or augmentation of the host-cell re-
sponsiveness to many bioactive factors, e.g.
hormones, cytokines. They stimulate the ma-
turation and differentiation of several cells (e.g.
macrophages, T -cells) important for host-
defence mechanism.1 Many polyglucans of
plant, fungal and microbial origin belong to this
group.2 5 Some of them manifest antitumour,
antimetastatic and anti-infectious activity, pro-
tect against cancer recurrence and carcinogen-
esis, and are used clinically as immuno-
potentiators in cancer therapy.5 7 However, the
cellular and molecular mechanisms of these
immune response modi￿cations are still not
understood. A number of investigators have
reported the existence of a speci￿c b-glucan
receptor on phagocytes,8 10 NK11 and micro-
glial cells.12 The binding of (1 3)-b-D-glucans
to these receptors is thought to be the ￿rst step
in mediating the effect of these poly-
glucans, 13 15 but the precise nature of the b-
glucan receptor has not been elucidated. The
best known member of the b-glucan family,
lentinan, was isolated by Chihara et al.1 from an
edible mushroom known as a folk remedy
against cancer in Japan and China. Its antitu-
mour and antimetastatic effectiveness was con-
￿rmed in the therapy of stomach, breast and
colorectal cancer.5 The biological activities of b-
glucans vary because of the differences in their
physicochemical properties, such as the length
of polyglucans, degree of branching, high order
structure, micelle formation and substitu-
tions.2,14,16 18 Sulphated polysaccharides includ-
ing curdlan sulphates (a semisynthetic linear
sulphated polysaccharide of bacterial origin) are
known as potent inhibitors of HIV replication
in vitro.19,20 Curdlan sulphate (CS) inhibits
attachment of the virus to T -cells and in phase I
clinical trial CS was found to be well toler-
ated.21,22 CS is also considered as an alternative
to heparin because of its anticoagulant activity
with minimal side-effects (i.e. bleeding).23 Cur-
dlan application in the controlled drug delivery
is also postulated.24 In this paper the modula-
tory effects of CS on basal and interleukin-6
stimulated protein production in HepG2 cells
were analysed. For comparison, along with
several secreted plasma proteins the typical
inducible intracellular enzyme (MnSOD) was
assayed. Selected proteins were determined by
immunoelectrophoresis, mRNAs by Northern
blot hybridization and EMSA was used for the
evaluation of nuclear factor NF- B and C/EBP
binding activity.
Materials and Methods
Reagents
Dulbecco’s modi￿ed Eagle’s medium (DMEM)
and fetal calf serum (FCS) were from Gibco
Life Technologies Inc. (Grand Island, NY);
[a-32P]dCTP and [c-32P]ATP were obtained from
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lan sulphate (molecular weight: 7 2 3 104, S
content: 14% , water: 5 6% ) was kindly provided
by Ajinomoto Co., Inc., Tokyo, Japan, and
human recombinant IL-6 by Dr Heinz Baumann
(Roswell Park Cancer Institute, Buffalo, NY,
USA). Antisera to human proteins were from
ATAB (Stillwater, MI, USA), human antichymo-
trypsin cDNA probe and MnSOD cDNA probe
were from ATCC (USA). Oligonucleotide probes
were synthesized by Dr A. Okruszek, Molecular
and Macromolecular Research Center, Polish
Academy of Sciences, ￿o ´dz ´, Poland. All other
reagents were from Sigma (St Louis, MO, USA).
Tissue culture and plasma protein
assay
HepG2 cells were grown at 378 Cin 6-well tissue
culture dishes (Costar) in DMEMsupplemented
with 10% FCS and antibiotics under a humidi-
￿ed atmosphere of 95%air and 5%CO2. After
they reached the stage of subcon￿uent mono-
layer, the medium was changed for serum-free
DMEM containing 1 mM dexamethasone and 5
units of heparin/ml and tested factors i.e.
curdlan sulphate (50 or 150 mg/ml), IL-6 (50 ng/
ml) or the mixture of CS and IL-6 were added.
After 24 h, the media were collected, dialysed,
concentrated and the production of selected
plasma proteins were measured by electroim-
munoassay as described by Koj et al.25
The isolation of RNA and Northern
blot analysis
For RNA preparations HepG2 cells were
cultured in 60-mm dishes (Costar) and when
the cells were nearly con￿uent, curdlan
sulphate (100 mg/ml), IL-6 (50 ng/ml) or the
mixture of these two tested factors were added
in serum-free DMEM. For SOD mRNA prepara-
tion, cells were harvested 6 h later, and for
antichymotrypsin mRNA, 24 h after treatment.
T otal RNA was prepared using the phenol
extraction method and LiCl precipitation.26
Electrophoresis was performed in 1% agarose
containing 20 mMMOPS, 4 mMsodium acetate,
1 mM EDTA and 2.2 M formaldehyde, and the
separated RNA was transferred to Hybond-N
membranes (Amersham, UK). Speci￿c mRNAs
were detected by hybridization of the mem-
branes at 68oC in 10% dextran sulphate, 1 M
NaCl and 1% SDS with EcoRI fragment of the
pUC 19-ACT clone for human antichymotrypsin
(ACT), or PstI± XbaI fragment derived from
pHcGAP plasmid for human GAPDH, or EcoRI
fragment of the phMnSOD4 clone for human
MnSOD labelled with 32P-dCTP by random
priming.27 To normalize hybridization signals for
variations in loading and/or transfer, membranes
were probed for GAPDH mRNA. Densitometry
of the bands was performed using a computer
imaging (MCID) system (Imaging Research Inc.,
Canada).
Nuclear protein extraction
Nuclear extracts were prepared by the mini-
extraction procedure.28 Brie￿y, cells were
scraped from plates 60 min after treatment with
the tested factors, washed twice with cold PBS
and centrifuged for 5 min at 400 3 g. Pelleted
cells resuspended in buffer containing 10 mM
HEPES (pH 7.8), 10 mM KCl, 2 mM MgCl2,
1 mM DTT , 0.1 mM EDTA and 0.1 mM PMSF
were incubated on ice for 15 min. Twenty-￿ve
ml of 40% Nonidet P-40 was added and, after
mixing, centrifuged for 30 s at 14000 rpm.
Pelleted nuclei were suspended in buffer con-
taining 50 mM HEPES, 50 mM KCl, 300 mM
NaCl, 0.1 mM EDTA, 1 mM DTT and 0.1 mM
PMSF , after 20 min centrifuged for 5 min at
14000 rpm at 48 C and supernatants frozen in
10% glycerol. The protein concentration was
determined by Lowry’s method.
EMSA
DNA mobility shift assay was carried out as
described by Duyao et al.29 A double-stranded
oligonucleotide that contained two binding sites
for NF- B (59 -AAGTCCGGGTTTTCCCCAACC-39 )
from the murine c-myc oncogene correspond-
ing to bp-1101-1081 was used. The C/EBP oligo-
nucleotide (59 -GATCTGGTATGATTTGTAATG-
GGGTAGGA-39 ) was from human albumin
promoter.30 The double-stranded oligonucleo-
tide probes used in gel shift analysis were either
end-labelled using [c-32P]ATP and T4 polynu-
cleotide kinase (NF- B), or labelled with [a-
32P]dCTP and Klenow polymerase using the
second 9-nucleotide long strand annealed as the
primer (C/EBP). Five mg of nuclear proteins
were used for incubation with 0.5 ng
(c.105cpm) of labelled oligonucleotide. As com-
petitors, a 100-fold excess of the oligonucleo-
tide was added to the binding reaction.
Statistical analysis
Data were analysed by paired Student’s t-test.
The statistical differences were evaluated in
pairs: control± CS 50 mg/ml; control± 150 mg/ml
or IL-6± IL-6 CS 50 mg/ml; IL-6± IL-6 CS
150 mg/ml.
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Curdlan sulphate affects protein
synthesis
The effects of curdlan sulphate, IL-6 and the
mixture of CS and IL-6 on the concentrations of
selected proteins in the medium of HepG2 cell
culture are presented in Fig. 1. The dose of CS
was chosen based on previous experiments
(data not shown). A considerable increase in
the concentration of ￿brinogen (FBG) and anti-
chymotrypsin (ACT), and moderate enhanced
ceruloplasmin (CER) in the medium after incu-
bation of HepG2 cells with CS for 24 h, is
contrasted with small changes in transferrin
(TRF) and alpha-1-proteinase inhibitor (API). As
shown earlier by Koj et al.,31 IL-6 strongly
enhanced ACT and FBG production in HepG2
cells, moderately increased CER and API con-
centrations and slightly diminished TRF produc-
tion. Curdlan sulphate modulated the effect of
IL-6 on protein synthesis but it seems that the
action of the two tested factors was not additive
(Figs 1 and 2a). As is shown in Fig. 2, CS not
only increased basal and IL-6-stimulated FBG
synthesis but also partly reversed the inhibitory
effect of IL-1 on FBG production (Fig. 2b) as
this cytokine is known to inhibit FBG synthesis
in vitro.32
The effect of CS and/or IL-6 on cellular mRNA
level for ACT was measured. Antichymotrypsin
mRNA level was determined by Northern blot
analysis and relative quantity evaluated using
scanner. Equal loading of lanes was established
by hybridizing the same blot with an GAPDH
cDNA probe. It was found that CS (100 mg/ml)
increased (about two-fold) the amount of ACT
mRNA (Fig. 3), suggesting that this b-glucan
induces antichymotrypsin gene transcription in
HepG2 cell line, though not as distinctly as IL-6
(Fig. 3).33 CS, in the mixture with IL-6 (50 ng/
ml) exert, however, only minor additive effect
on ACTgene transcription.
The in¯ uence of curdlan sulphate on
MnSOD mRNA
The effect of CS or/and IL-6 on the expression
of intracellular protein, manganese superoxide
dismutase mRNA in HepG2 cells was also stud-
ied. Northern analysis showed that MnSOD
mRNA was mainly expressed in the presence of
IL-6 (Fig. 4), while curdlan sulphate slightly
diminished basal and IL-6 stimulated expression
of this mRNA (by 30% ). Similar pictures were
obtained in three experiments.
Effect of curdlan sulphate on the
binding activity of transcription
factors
T o examine the involvement of transcription
factors in the regulatory effects of curdlan
sulphate the nuclear extracts prepared from
untreated, CS-, IL-6- or CS IL-6- treated HepG2
cells were subjected to EMSA. The results
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FIG. 1. Effect of curdlan sulphate (CS) on basal and interleukin-6-stimulated production of ® brinogen (FBG), anti-
chymotrypsin (ACT), ceruloplasmin (CER), alpha-1-proteinase inhibitor (API) and transferrin (TRF) in HepG2 cells cultured for
24 h with the drug. The results are expressed in relative terms, protein content in control culture was assumed as 100. Mean
of three to four experiments, SD. In condition used, control culture cells produced: 14.1 mg FBG, 2.1 mg ACT, 0.6 mg CER and
9.3 mg API. The increase in basal and IL-6 stimulated FBG and ACT production in comparison, respectively, with control or IL-
6 treated culture is statistically signi® cant (P , 0 01). Basal CER synthesis in the presence of CS (150 mg/ml) is also
signi® cantly different (P , 0 05) from the value for control.
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binding to DNA in HepG2 cells more ef￿ciently
than IL-6 and the combined effect of these
drugs were not additive. We found that CS also
slightly enhanced binding of transcription fac-
tors belonging to the C/EBP family in HepG2
cells.
Discussion
Several years ago Maeda et al.41 found that
lentinan administration to the mouse resulted in
an increase of three types of serum proteins.
They observed a close relationship between the
antitumour activity of this b-glucan and en-
hancement of protein components. Subsequent
FIG. 2. Rocket immunoelectrophoresis of ® brinogen (FBG) produced by HepG2 cells cultured for 24 h with curdlan sulphate
(CS) and/or IL-6 (a); CS and/or IL-1 (b).
FIG. 3. The in¯ uence of curdlan sulphate (CS) (100 mg/ml)
and/or IL-6 (50 ng/ml) on antichymotrypsin (ACT) gene
expression (ACT mRNA) in HepG2 cells after 24 h incuba-
tion. As control, the same blot was hybridized with a
GAPDH cDNA probe. The autoradiogram was densitometri-
cally scanned, and the amount of ACT mRNA was ex-
pressed in arbitrary units, after normalizing against GAPDH
mRNA control.
FIG. 4. The in¯ uence of curdlan sulphate (100 mg/ml), IL-6
(50 ng/ml) and the mixture of these factors on MnSOD
mRNA in HepG2 cells cultured for 8 h. For comparison,
mRNA for GAPDH is given. The results of one of three
different experiments is shown. Scanning data are pre-
sented in arbitrary units.
Mediators of In¯ ammation ´ Vol 6 ´ 1997 61
Curdlan sulphate and protein synthesisstudies revealed that lentinan stimulated the
production of acute phase proteins (APPs) in
vivo.42 The APP response to lentinan was of
delayed type, genetically controlled and lentinan
acted at certain optimal concentration. In our
in vitro studies CS, another b-glucan, also
induced APPs in hepatoma cells and diminished
intracellular enzyme MnSODmRNAlevel.
The experiments described here demonstrate
that CS in￿uence protein synthesis and tran-
scription factors binding activity in human
hepatoma HepG2 cells. Among the proteins
tested, especially in￿uenced by curdlan sul-
phate is ￿brinogen, and, to a lesser extent,
antichymotrypsin. It appears, that CS may mod-
ulate protein synthesis, at least in part, at the
pretranslational level, and some of its effects are
probably mediated by transcription factors NF-
B and C/EBP. The transcriptional regulation of
serum protein genes is extremely complex and
different cellular or environmental stimuli can
distinctly alter their expression.31,34 The most
important role in the induction of serum
protein genes is exerted by interleukin 6.35,36
The induction is mediated by interleukin-6
response elements (IL-6 RE I and II). IL-6 RE I
can interact with the proteins of C/EBP family
and it is postulated, that this transcription factor
as well as NF- B play a regulatory role in the
enhanced hepatic and cytokine-induced expres-
sion of serum protein genes. 37 39 Moreover, the
synergy between NF- Band C/EBP transcription
factor families in the activation of some protein
genes has been documented.40
Host defence potentiators affect the host
metabolism, but are not cytotoxic to the
tumour. It is possible, however, that CS and
other bioactive polyglucans can in￿uence
protein synthesis in host and in hepatomas as
well. It would be of interest to compare CS
effects on control liver cells and hepatoma
cells. Following this notion, the inhibition of
MnSODmRNAexpression by CS may contribute
to its antitumour effect, as MnSOD is one of
the major cellular defence enzymes which
protects superoxide radicals from toxic
effects. 43 The 39 -￿anking region of the MnSOD
gene contains one NF- B consensus sequence,
which suggests that this potential regulatory
element may play a role in the up-regulation of
human MnSOD gene expression.44 Since CS
increases NF- B binding activity and simulta-
neously down-regulates MnSOD gene, other
mechanism(s) are possibly involved in the
inhibition of MnSOD mRNA by CS. Borello et
al.45 recently showed that metals (iron, copper)
are involved in the regulation of the MnSOD
gene in rat liver. Thus the in￿uence of CS on
serum proteins, including the proteins which
participate in metal distribution might be of
importance.
In summary, we have shown that sulphated
polyglucan, curdlan sulphate, can change
protein synthesis, at least in part, at the
pretranslational level, probably through the
activation of NF- B and C/EBP in the human
hepatoma HepG2 cell line. It should be noted
that observed alterations caused by CS are not
FIG. 5. Electrophoretic mobility shift assay of nuclear extracts isolated from control, curdlan sulphate- (100 mg/ml), IL-6-
(50 ng/ml), or CS IL-6-treated HepG2 cells after 60 min incubation. Double-stranded oligonucleotides, NF- B and C/EBP were
described in Materials and Methods. Densitometry scans are expressed in arbitrary units. Typical example of three
experiments.
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modi￿ers should act in a moderate way.
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